trending Market Intelligence /marketintelligence/en/news-insights/trending/Z0ovWqb7Oji1AT749kfznw2 content esgSubNav
In This List

Suda proposes 25-to-1 share consolidation to address price volatility

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Suda proposes 25-to-1 share consolidation to address price volatility

Suda Pharmaceuticals Ltd. is proposing a 25-to-1 consolidation of its shares to mitigate certain share price issues.

If shareholders approve the consolidation at the company's general meeting on Nov. 12, the issued shares in Suda will decrease to about 142 million shares from about 3.6 billion shares. Following approval, options will also be reorganized and consolidated in the same ratio.

The exercise price of the options will also be adjusted in inverse proportion to the consolidation's ratio.

Suda Pharmaceuticals is a drug delivery company focusing on oro-mucosal administration.